Immunomodulatory drugs in type 1 diabetes mellitus: current status and future prospects / 中国医师杂志
Journal of Chinese Physician
;
(12): 11-15, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-734056
ABSTRACT
The pathophysiological nature of type 1 diabetes mellitus (T1DM) as an autoimmune disease provides the basis for immunotherapy.As an important therapeutic approach,immunomodulatory drugs are promising in the protection of pancreatic β-cells by effecting at various stages of autoimmune progression.In this review,we summarize the recent advances of immunomodulatory drugs in the prevention and treatment of T1DM and propose future directions.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Chinese Physician
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS